Andere talen Northwest Biotherapeutics, Inc.

Aandelen

NWBO

US66737P6007

Vertraagde tijd OTC Markets Andere beurzen 20:02:15 03-05-2024			Variatie 5 dagen	Verschil t.o.v. 1 jan (%)
0,47 ^USD	+0,87%		-3,09%	-32,95%

21/03	Northwest Biotherapeutics, Inc. Benoemt Pat Sarma tot lid van de Raad van Bestuur	CI
14/03	Northwest Biotherapeutics, Inc. kondigt aan dat Jerry Jasinowski terugtreedt uit de Raad van Bestuur	CI

Andere talen

Krijg toegang tot al het nieuws over alle bedrijven: mis nooit meer een winstgevende beleggingskans!

Gratis inschrijven

Northwest Biotherapeutics, Inc. Appoints Pat Sarma to Its Board of Directors	21/03
Northwest Biotherapeutics, Inc. Announces Retirement of Jerry Jasinowski from the Board of Directors	14/03
Northwest Biotherapeutics, Inc. Reports Earnings Results for the Full Year Ended December 31, 2023	05/03
Northwest Biotherapeutics Moves From Optimization of Flaskworks Prototype to Fabrication of GMP-Compliant Units For Installation, Validation and Final Testing Prior to Regulatory Certification	06/02
Northwest Biotherapeutics announces that a Marketing Authorization Application has been submitted to the UK MHRA for DCVax-L for Glioblastoma	22/12
Northwest Biotherapeutics Announces That A Marketing Authorization Application Has Been Submitted To The UK MHRA For DCVax®-L For Glioblastoma	21/12
Northwest Biotherapeutics Announces Marketing Authorization Application Has Been Submitted to the UK MHRA for DCVax-L for Glioblastoma	21/12
Northwest Biotherapeutics Provides Update On Final Preparations For Marketing Authorization Application	22/11
Northwest Biotherapeutics, Inc. announced that it has received $11.005 million in funding from Streeterville Capital, LLC	10/11
Northwest Biotherapeutics, Inc. Reports Earnings Results for the Third Quarter and Nine Months Ended September 30, 2023	09/11
Today's Top Nano-Cap Stock Watchlist (MGUY, AABB, NWBO, ICU)	19-10-23
Northwest Biotherapeutics Provides Update on Near Term Plans for Submission of Marketing Authorization Application	16-10-23
Northwest Biotherapeutics Provides Update On Near Term Plans For Submission of Marketing Authorization Application	13-10-23
Companies Spotlighted on "The Street Reports Podcast" Unveiling Secrets to Success: CLNV, HNRC, NWBO, ASRE	28-09-23
Penny Stock Momentum List (ATVK, ELTP, NWBO, ENZC)	25-09-23
Penny Stocks Set To Soar On News Watchlist (TBRIF, NWBO, IQST, TLOFF)	14-09-23
Today's OTC Momentum Watchlist (RGGI, DLOC, NWBO, HMBL)	13-09-23
Northwest Biotherapeutics Announces That Dr. Linda Liau Has Joined The Company's Scientific Advisory Board	12-09-23
Northwest Biotherapeutics Appoints Linda Liau to its Scientific Advisory Board	12-09-23
Northwest Biotherapeutics Announces Completion of Prerequisites, and Plans for Submission of Marketing Authorization Application	29-08-23

Geen resultaten voor deze zoekopdracht

Al het nieuws Aanbevelingen van analisten Belangrijkste gebeurtenissen Insiders Transcripties Persberichten Officiële publicaties Andere talen Ideeën voor de handel MarketScreener-artikels MarketScreener-analyses

Andere talen Northwest Biotherapeutics, Inc.

Aandelen

NWBO

US66737P6007

Andere talen

Filters